Here’s My Top Growth Stock to Buy Right Now

Although investors have several high-quality choices of stocks to buy in this environment, here’s my top growth stock to buy right now!

| More on:
potted green plant grows up in arrow shape

Image source: Getty Images

After a consistent selloff all year, there are numerous high-quality growth stocks to buy in this environment. Furthermore, plenty of these top growth stocks trade at attractive valuations that we haven’t seen for years, making this the ideal time to put your capital to work.

If you’re looking for just a single stock to buy today, though, it’s crucial to focus on companies that could have catalysts for growth in this environment.

While there are plenty of growth stocks trading cheaply, especially in sectors such as tech, it still could be some time before many of these stocks begin to recover fully.

But one stock that has a tonne of growth potential is trading undervalued and could continue to operate well and grow in this environment is Neighbourly Pharmacy (TSX:NBLY).

Neighbourly’s defensive qualities make it ideal in this market environment

As the market continues to face severe uncertainty, finding growth stocks that also offer defensive qualities is ideal. That’s why a high-quality stock like Neighbourly, which operates in the healthcare space, is my top growth stock to buy now.

Throughout the last few months, many stories that have dominated media headlines have revolved around consumers’ budgets being impacted and how that could weigh on consumer spending.

Yet at the same time, as the flu season approaches and COVID-19 cases increase again, we’re also seeing an increase in spending on pharmaceuticals and over-the-counter drugs, which has led to shortages.

This is a good reminder for investors that companies like Neighbourly that sell these essential products can be ideal investments in this high-inflation environment.

Of course, Neighbourly is also consistently growing by acquisition, so, naturally, its revenue will increase each quarter.

However, in Neighbourly’s most recent earnings report (its fiscal 2023 second quarter), the stock also reported same-store sales growth (SSSG) for pharmacy revenue that was up 4.2% year over year. This goes to show that even as consumers may be spending less on discretionary items, Neighbourly and the essential items it sells are more immune to these economic conditions.

The bulk of Neighbourly’s growth, however, has come from the consistent acquisitions it’s made, now with over 275 pharmacies in its portfolio across the country.

Neighbourly’s impressive acquisitions make it my top growth stock to buy now

While SSSG accounted for an increase in pharmacy revenue and store-front revenue by 4.2% and 2.9%, respectively, in Neighbourly’s last quarter, the bulk of its growth came from the new acquisitions it made.

In total, Neighbourly reported year-over-year growth in its sales of more than 97%. In addition, its margins also slightly increased at a time when inflation has been shrinking many other companies’ margins. The higher margins helped Neighbourly to report year-over-year earnings before interest, taxes, depreciation and amortization (EBITDA) growth upwards of 98% year over year.

This just goes to show how well Neighbourly is operating and how well its acquisitions are paying off. Not only is the company seeing an increase in revenue, but it can also start to experience important synergies, which will help lower its costs.

In total, for fiscal 2023, analysts expect Neighbourly’s revenue to increase by over 77% and another 25% in its fiscal 2024 year.

Therefore, while Neighbourly trades at an enterprise value (EV) to EBITDA ratio of just 11.6 times, which is down from more than 20 times at the start of the year, it’s my top growth stock to buy.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Daniel Da Costa has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

More on Investing

sale discount best price
Dividend Stocks

2 Remarkably Cheap TSX Stocks I’d Buy Right Now

Cheap and undervalued TSX stocks such as goeasy can offer investors the opportunity to generate outsized returns next year.

Read more »

TFSA and coins
Dividend Stocks

TFSA Investors: How to Make Passive Income in 2024

These two passive-income stocks offer growth and dividends but should also remain stable going into 2024 and beyond.

Read more »

Dividend Stocks

Should You Buy This High-Growth Utility Stock Today?

While from a typically "boring" sector, this TSX utility stock offers unusually high growth potential if you are interested in…

Read more »

A close up image of Canadian $20 Dollar bills

3 No-Brainer Stocks to Buy With $100 Right Now

A small investment of $100 in these Canadian stocks could result in solid capital gains in the long term.

Read more »

Baubles On Snow With Snowy Christmas Tree
Dividend Stocks

3 TSX Stocks to Buy in December 2023

Here's why quality TSX stocks such as Jamieson Wellness should be part of your shopping list in December 2023.

Read more »

Value for money
Tech Stocks

2 Top Value Stocks to Buy in December 2023

With healthy growth prospects and discounted share prices, I am bullish on these two Canadian value stocks.

Read more »

analyze data
Dividend Stocks

Adjusting Your Portfolio for the New Normal: Higher Interest Rates in Canada

The 5% interest rate is here to stay until the second half of 2024. It's time to adjust your portfolio…

Read more »

stock research, analyze data
Dividend Stocks

2 Top Stocks to Buy With $500 Today

Investing in the stock market does not always require massive capital. You can begin with just $500 allocated to stocks…

Read more »